Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/5/24 19:03 | 2/1/24 | CHRS | Health | BioPrd | Biological Products, (No Diag | Wahlstrom Mats | CA | D | M.d | 100 | 1.67 | 0 | 60 | 150 | 100 | D | |||||||||||||||
11/24/23 16:04 | 11/22/23 | CHRS | Health | BioPrd | Biological Products, (No Diag | Lanfear Dennis M | CA | DO | P,CEO | M.d | 425 | 1.42 | 0 | 300 | 32 | 1,251 | D | ||||||||||||||
11/24/23 16:04 | 11/22/23 | CHRS | Health | BioPrd | Biological Products, (No Diag | Lanfear Dennis M | CA | DO | P,CEO | S.d | -450 | 2.02 | 0 | -223 | -15 | 1,251 | D | ||||||||||||||
10/19/21 19:36 | 10/15/21 | CHRS | Health | BioPrd | Biological Products, (No Diag | Stilwell McDavid | CA | O | CFO | S | -59 | 16.80 | 0 | -4 | -10 | 32 | D | ||||||||||||||
9/29/21 20:18 | 9/27/21 | CHRS | Health | BioPrd | Biological Products, (No Diag | Healy James | CA | D | S.m | -7,250 | 16.68 | 0 | -435 | -86 | 70 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |